Gene · 9401
Papers1,646
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,646
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RECQL4-related Rothmund-Thomson syndrome: A case series and literature review. | Cancer Genet | 2025 | 40031098 | PubTator, text mining | PubMed |
| Targeting RECQL4 in hepatocellular carcinoma: from prognosis to therapeutic potential. | BMC Med Genomics | 2025 | 40001159 | PubTator, text mining | PubMed |
| Exome-based cancer predisposition gene testing can provide a genetic diagnosis for individuals with heterogeneous tumor phenotypes. | Eur J Hum Genet | 2025 | 39979679 | PubTator, text mining | PubMed |
| RECQ4-MUS81 interaction contributes to telomere maintenance with implications to Rothmund-Thomson syndrome. | Nat Commun | 2025 | 39900600 | PubTator, text mining | PubMed |
| RECQL4 requires PARP1 for recruitment to DNA damage, and PARG dePARylation facilitates its associated role in end joining. | Exp Mol Med | 2025 | 39870799 | PubTator, text mining | PubMed |
| HER2 expression and pathway status in male breast cancer patients: results of an integrated analysis among 6,150 patients. | Sci Rep | 2025 | 39870698 | PubTator, text mining | PubMed |
| RECQL4 affects MHC class II-mediated signalling and favours an immune-evasive signature that limits response to immune checkpoint inhibitor therapy in patients with malignant melanoma. | Clin Transl Med | 2025 | 39812592 | PubTator, text mining | PubMed |
| Bioinformatics Based Drug Repurposing Approach for Breast and Gynecological Cancers: RECQL4/FAM13C Genes Address Common Hub Genes and Drugs. | Eur J Breast Health | 2025 | 39744927 | PubTator, text mining | PubMed |
| Interaction of RECQL4 with poly(ADP-ribose) is critical for the DNA double-strand break response in human cells. | FEBS Open Bio | 2025 | 39462683 | PubTator, text mining | PubMed |
| Severe Phenotype With RECQL4 Syndrome: A Report of Two Cases. | Am J Med Genet A | 2025 | 39324487 | PubTator, text mining | PubMed |
| Novel Syndrome With Congenital Thumb Aplasia, Epilepsy, Cognitive Impairment, and Myopathy: A Case Report. | Cureus | 2024 | 39850168 | PubTator, text mining | PubMed |
| Increased frequency of CHEK2 germline pathogenic variants among individuals with dermatofibrosarcoma protuberans. | Genet Med Open | 2024 | 39669616 | PubTator, text mining | PubMed |
| Germline Variants in DNA Interstrand-Cross Link Repair Genes May Contribute to Increased Susceptibility for Serrated Polyposis Syndrome. | Int J Mol Sci | 2024 | 39519399 | PubTator, text mining | PubMed |
| G-quadruplex DNA and RNA in cellular senescence. | Front Aging | 2024 | 39444378 | PubTator, text mining | PubMed |
| RecQ protein-like 4 drives cisplatin chemosensitivity of cervical cancer cells by modulating annexin A2. | Drug Dev Res | 2024 | 39404003 | PubTator, text mining | PubMed |
| CREB1 regulates RECQL4 to inhibit mitophagy and promote esophageal cancer metastasis. | J Clin Biochem Nutr | 2024 | 39345293 | PubTator, text mining | PubMed |
| Atypical presentations of RECQL4-related syndromes. | Pediatr Blood Cancer | 2024 | 39315607 | PubTator, text mining | PubMed |
| USP50 suppresses alternative RecQ helicase use and deleterious DNA2 activity during replication. | Nat Commun | 2024 | 39284827 | PubTator, text mining | PubMed |
| Prevalence of germline variants in Brazilian pancreatic carcinoma patients. | Sci Rep | 2024 | 39256447 | PubTator, text mining | PubMed |
| Amplified Cell Cycle Genes Identified in High-Grade Serous Ovarian Cancer. | Cancers (Basel) | 2024 | 39199556 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9401/papers?page=4